Back
Merus NV Vs. ProQR Therapeutics NV Industry Stock Comparison
Buy
64
MRUS
Merus NV
Last Price:
44.03
Seasonality Move:
12%
Buy
53
PRQR
ProQR Therapeutics NV
Last Price:
1.94
Seasonality Move:
6.7%
Buy
64
Merus NV (MRUS)
is a Buy
Is Merus NV a Buy, Sell or Hold?
- The current Merus NV [MRUS] share price is $43.91. The Score for MRUS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- MRUS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $1.94. The Score for PRQR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MRUS Stock Price Chart
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $1.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
MRUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 46.04 | Sell |
| Chaikin Money Flow: | -304848 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.58 - 46.96) | Sell |
| Bollinger Bands (100): | (35.07 - 47.55) | Buy |
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 42.28 | Sell |
| Chaikin Money Flow: | -45529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.93 - 2.01) | Sell |
| Bollinger Bands (100): | (1.92 - 2.28) | Sell |
MRUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.19 | Sell |
| 20-day SMA: | 45.19 | Sell |
| 50-day SMA: | 44.51 | Sell |
| 200-day SMA: | 32.2 | Buy |
| 8-day EMA: | 45.12 | Sell |
| 20-day EMA: | 45.05 | Sell |
| 50-day EMA: | 43.97 | Sell |
| 200-day EMA: | 35.21 | Buy |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.96 | Sell |
| 20-day SMA: | 1.98 | Sell |
| 50-day SMA: | 2.13 | Sell |
| 200-day SMA: | 1.81 | Buy |
| 8-day EMA: | 1.96 | Sell |
| 20-day EMA: | 1.99 | Sell |
| 50-day EMA: | 2.05 | Sell |
| 200-day EMA: | 1.96 | Sell |
Merus NV Earnings Growth & MRUS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.37 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.25 per share.
Merus NV Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProQR Therapeutics NV Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||